April 10, 2025 | Co-author working group, DOL engagement, Engage advisors, HCP engagement, Impetus Digital, KOL Engagement, MSL engagement, Patient journey, Patient journey mapping, Pharma tips, Pharma trends, Virtual collaboration, advisor engagement, engage hcps, healthcare gaps, pharma collaboration
Improve patient experiences! Learn how to co-create patient journey maps with your advisors virtually, identify healthcare gaps, and streamline care pathways.

You can effectively map the patient journey using virtual collaboration. Leverage virtual co-author working groups to create detailed patient journey maps, identify healthcare gaps, and improve patient experiences and outcomes. Learn how the Impetus InSite Platform® empowers advisors to participate equally and on their own time, leading to streamlined patient journeys and better care.
2. Creation of Patient Journey Maps
For more creative ways to engage your advisors, visit:
Learn more about Impetus Digital’s solutions:
Schedule a free consultation:
https://meetwithimpetus.com
Stay connected:
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today’s diverse healthcare landscape. 7….
Join us for a look at the top-5 emerging virtual collaboration trends…
As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here’s another one to keep in…
Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care…
Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform…
In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal…
Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive…
Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #9. No More “White Space” Between Live Meetings Clearly, the…
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access.
Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #8. The Ease and Effectiveness of Sharing Knowledge and Data…
